The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse modelTatsuzo Mizukami, Akinobu Taketomi|Oncotarget|2018Cited by 33